Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication
Pathology - Research and Practice · 2024-02 · 254 · 155148
DOI: 10.1016/j.prp.2024.155148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024-02. Verfasst von Shinsuke Fujii und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidash…. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Kaibara Morikazu Medical Science Promotion Foundation, Takeda Science Foundation, Terumo Foundation for Life Sciences and Arts.
Abstract (Originalsprache)
Adenoid cystic carcinoma (ACC) is one of the most common malignant salivary gland tumors. ACC is composed of myoepithelial and epithelial neoplastic cells which grow slowly and have a tendency for neural invasion. The long term prognosis is still relatively poor. Although several gene abnormalities, such as fusions involving MYB or MYBL1 oncogenes and the transcription factor gene NFIB, and overexpression of KIT have been reported in ACC, their precise functions in the pathogenesis of ACC remain unclear. We recently demonstrated that the elevated expression of Semaphorin 3A (SEMA3A), specifically expressed in myoepithelial neoplastic cells, might function as a novel oncogene-related molecule to enhance cell proliferation through activated AKT signaling in 9/10 (90%) ACC cases. In the current study, the patient with ACC whose tumor was negative for SEMA3A in the previous study, revisited our hospital with late metastasis of ACC to the cervical lymph node eight years after surgical resection of the primary tumor. We characterized this recurrent ACC, and compared it with the primary ACC using immunohistochemical methods. In the recurrent ACC, the duct lining epithelial cells, not myoepithelial neoplastic cells, showed an elevated Ki-67 index and increased cell membrane expression of C-kit, along with the expression of phosphorylated ERK. Late metastasis ACC specimens were not positive for β-catenin and lymphocyte enhancer binding factor 1 (LEF1), which were detected in the nuclei of perineural infiltrating cells in primary ACC cells. In addition, experiments with the GSK-3 inhibitor revealed that β-catenin pathway suppressed not only KIT expression but also proliferation of ACC cells. Moreover, stem cell factor (SCF; also known as KIT ligand, KITL) induced ERK activation in ACC cells. These results suggest that inactivation of Wnt/β-catenin signaling may promote C-kit-ERK signaling and cell proliferation of in metastatic ACC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; Dento-craniofacial Development…
- Laboratory of Oral Pathology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
- Dento-craniofacial Development and Regeneration Research Center, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan; Section of Oral and Maxillofacial Oncology, Division of…
- Institute of Biomedicine and MediCity Research Laboratories, University of Turku, and Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku FI-20520, Finland.
- Department of Oral and Maxillofacial Surgery, Institute of Dentistry, University of Turku and Turku University Hospital, FI-20520, Finland.
- Department of Cariology, Restorative Sciences, and Endodontics, University of Michigan School of Dentistry, Ann Arbor, MI, USA.
Förderung
- Kaibara Morikazu Medical Science Promotion Foundation
- Takeda Science Foundation
- Terumo Foundation for Life Sciences and Arts
- Shinnihon Foundation of Advanced Medical Treatment Research
- Fukuoka Public Health Promotion Organization Cancer Research Fund
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Japan Society for the Promotion of Science
Zitieren
APA
Fujii, S., Hasegawa, K., Maehara, T., Kurppa, K. J., Heikinheimo, K., Warner, K. A., Maruyama, S., Tajiri, Y., Nör, J. E., Tanuma, J. I., Kawano, S., & Kiyoshima, T. (2024). Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication. Pathology - Research and Practice, 254, 155148. https://doi.org/10.1016/j.prp.2024.155148
Vancouver
Fujii S, Hasegawa K, Maehara T, Kurppa KJ, Heikinheimo K, Warner KA, et al. Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication. Pathology - Research and Practice. 2024;254:155148. doi:10.1016/j.prp.2024.155148
BibTeX
@article{Fujii2024,
author = {Fujii, Shinsuke and Hasegawa, Kana and Maehara, Takashi and Kurppa, Kari J and Heikinheimo, Kristiina and Warner, Kristy A and Maruyama, Satoshi and Tajiri, Yudai and Nör, Jacques E and Tanuma, Jun-Ichi and Kawano, Shintaro and Kiyoshima, Tamotsu},
title = {Wnt/β-catenin-C-kit axis may play a role in adenoid cystic carcinoma prognostication},
journal = {Pathology - Research and Practice},
year = {2024},
volume = {254},
pages = {155148},
doi = {10.1016/j.prp.2024.155148}
}
EUVIMED